XML 61 R32.htm IDEA: XBRL DOCUMENT
v3.25.4

Accounting Standards and Basis of Preparation (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2025
Accounting Standards and Basis of Preparation [Abstract] |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries | The subsidiaries of the Group, all of which have been included in the consolidated financial statements of the Group, are as follows:
Name |  | Principal activities |  | Country of incorporation and principal place of business |  | Ref |  | % Equity interest 06/30/2025 |  |  | % Equity interest 06/30/2024 |
Moolec Science Limited |  | Investment in subsidiaries |  | United Kingdom |  | b) |  |  | 100 | % |  |  | - |
AG Biomolecules LLC |  | Production and commercialization of agricultural products |  | United States |  | b) |  |  | 100 | % |  |  | - |
ValoraSoy S.A. |  | Production and commercialization of agricultural products |  | Argentina |  | b) |  |  | 100 | % |  |  | - |
Nutrecon LLC |  | Investment in subsidiaries |  | United States |  | b) |  |  | 100 | % |  |  | - |
SynBio Powerlabs |  | Production and commercialization of fermentation products |  | Finland |  | d) |  |  | 90 | % |  |  | - |
Gentle Tech |  | Investment in subsidiaries |  | British Virgin Islands |  | a),b) |  |  | 100 | % |  |  | 50 | %
Gentle Farming |  | Investment in subsidiaries |  | British Virgin Islands |  | a),b) |  |  | 51 | % |  |  | 51 | %
G-FAS |  | Production and commercialization of sustainable agricultural equipment |  | Argentina |  | a),b) |  |  | 64 | % |  |  | 64 | %
Bioceres Group Limited |  | Investment in subsidiaries |  | United Kingdom |  | b) |  |  | 100 | % |  |  | 100 | %
Bioceres Crop Solutions (BIOX) |  | Research and development |  | United States |  | c) |  |  | 29.30 | % |  |  | 28.75 | %
Bioceres LLC |  | Investment in subsidiaries |  | United States |  | a) |  |  | 100 | % |  |  | 100 | %
Bioceres S.A. |  | Investment in subsidiaries |  | Argentina |  | a) |  |  | 89.93 | % |  |  | 79.72 | %
Bioceres Tech Services LLC |  | Investment in subsidiaries |  | United States |  | a) |  |  | 100 | % |  |  | 100 | %
a) Direct interests held by Bioceres Group Limited. b) Direct interest held by Moolec Science SA. c) Since 2023, the Group exercises “de facto control” over Bioceres Crop Solutions Corp, however, as stated in note Note 1 – The Group’s business reorganization and general information - “The Bioceres Group Business Combination Agreement”, Bioceres Group Limited lost the “de facto control” on June 24, 2025. The subsidiary was deconsolidated as of June 30, 2025, and the investment in it was measured using the equity method. The Group’s consolidated result includes the results of that entity up to the date of its deconsolidation. No results related to the loss of control have been recognized. Various notes to the financial statements show the effect it has had on consolidated assets and liabilities, business segments and CGUs. d) Direct interest held by Nutrecon LLC.

X
- Definition The disclosure of interests in subsidiaries. [Refer: Total for all subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph 2 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_2_b_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | mlec_AccountingStandardsAndBasiofPreparationAbstract
Namespace Prefix: | mlec_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration